These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1584840)

  • 1. Antagonism of phencyclidine-induced hyperactivity in mice by elevated brain GABA concentrations.
    Seiler N; Grauffel C
    Pharmacol Biochem Behav; 1992 Mar; 41(3):603-6. PubMed ID: 1584840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (4S)-4-amino-5,6-heptadienoic acid (MDL 72483): a potent anticonvulsant GABA-T inhibitor.
    Sarhan S; Casara P; Knödgen B; Seiler N
    Neurochem Res; 1991 Mar; 16(3):285-93. PubMed ID: 1780030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced elevation of GABA after intracerebral microinjection: site of anticonvulsant action.
    Gale K; Iadarola M
    Eur J Pharmacol; 1980 Nov; 68(2):233-5. PubMed ID: 7202489
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model.
    Löscher W; Jäckel R; Müller F
    Eur J Pharmacol; 1989 Apr; 163(1):1-14. PubMed ID: 2744084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol on gamma-vinyl GABA-induced GABA accumulation in the substantia nigra and on synaptosomal GABA content in six rat brain regions.
    Frye GD; Fincher AS
    Brain Res; 1988 May; 449(1-2):71-9. PubMed ID: 3395859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal mobility-related theta activity is not diminished by vigabatrin, a GABAmimetic antiepileptic drug, in normal rats.
    Ylinen A; Koivisto E; Valjakka A; Sirviö J; Freund TF; Riekkinen P
    Brain Res Bull; 1992 Jan; 28(1):145-7. PubMed ID: 1540842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
    Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
    Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats.
    Rundfeldt C; Löscher W
    Eur J Pharmacol; 1992 Mar; 213(3):351-66. PubMed ID: 1618278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Neurology; 1996 May; 46(5):1459-63. PubMed ID: 8628502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen.
    Midgley LP; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Oct; 593(1):89-96. PubMed ID: 1360868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA in epilepsy: the pharmacologic basis.
    Gale K
    Epilepsia; 1989; 30 Suppl 3():S1-11. PubMed ID: 2548836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.
    Hauw JJ; Boutry JM; Sun P; Sazdovitch V; Duyckaerts C
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):47S-52S. PubMed ID: 2757909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One to three day dose intervals during subchronic treatment of epileptic gerbils with gamma-vinyl GABA: anticonvulsant efficacy and alterations in regional brain GABA levels.
    Löscher W; Frey HH
    Eur J Pharmacol; 1987 Nov; 143(3):335-42. PubMed ID: 3691661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
    Petroff OA; Behar KL; Mattson RH; Rothman DL
    J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempts to correlate alterations in brain GABA metabolism by GABA-T inhibitors with their anticonvulsant effects.
    Schechter PJ; Tranier Y; Grove J
    Adv Exp Med Biol; 1979; 123():43-57. PubMed ID: 517278
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor gamma-vinyl-GABA.
    Jacob JN; Hesse GW; Shashoua VE
    J Med Chem; 1990 Feb; 33(2):733-6. PubMed ID: 2299639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between phencyclidine (PCP) and GABA-ergic drugs: clinical implications.
    Menon MK; Clark WG; Vivonia C
    Pharmacol Biochem Behav; 1980 Jan; 12(1):113-7. PubMed ID: 7367454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.